Valuation : Omnicell, Inc.

Market Cap 1.52B 1.31B 1.23B 1.12B 2.12B 146B 2.12B 14.61B 5.7B 73.53B 5.72B 5.6B 244B P/E 2026 *
34x
P/E 2027 * 32.9x
Enterprise Value 1.52B 1.31B 1.23B 1.12B 2.12B 146B 2.12B 14.61B 5.7B 73.53B 5.72B 5.6B 244B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.18x
Free-Float
76.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.76%
1 week-6.52%
Current month-5.97%
1 month-22.74%
3 months-25.63%
6 months-19.37%
Current year-26.58%
1 week 32.96
Extreme 32.96
35.66
1 month 32.96
Extreme 32.96
44.27
Current year 31.75
Extreme 31.75
55
1 year 29.06
Extreme 29.06
55
3 years 22.66
Extreme 22.66
61.44
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
17/8/26 Sell

Chairperson

-3,083 0.0068%
15/8/26 Tax

Chief Executive Officer

-12,350 0.0272%
15/8/26 Tax

Chief Administrative Officer

-4,025 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%-6.52%-0.06%-41.47% 1.52B
-0.90%+13.76%+3.55%+48.12% 45.83B
+1.25%-11.91%-40.69%+150.25% 13.47B
+1.55%+3.45%-14.15%+68.09% 5.73B
-0.40%-3.38%+49.56% - 4.18B
-5.96%-7.57% - - 2.02B
+6.45%-6.54%-32.33% - 1.08B
-1.26%-2.02%+39.10%+152.72% 1.02B
-3.78%-1.57%+45.48%+59.58% 1.02B
+0.57%-0.28%-36.23%-43.59% 807M
Average -0.29%-1.06%+1.58%+56.24% 7.67B
Weighted average by Cap. -0.38%+5.17%-3.17%+68.26%

Financials

2026 *2027 *
Net sales 1.24B 1.07B 999M 912M 1.72B 118B 1.72B 11.86B 4.63B 59.68B 4.64B 4.54B 198B 1.29B 1.11B 1.04B 950M 1.79B 123B 1.8B 12.35B 4.82B 62.15B 4.84B 4.73B 206B
Net income 45.27M 39.01M 36.58M 33.39M 62.9M 4.33B 63.1M 434M 169M 2.18B 170M 166M 7.24B 47.37M 40.82M 38.27M 34.93M 65.81M 4.53B 66.02M 454M 177M 2.29B 178M 174M 7.58B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,485
Date Price Change Volume
29/08/26 US$33.24 -0.51% 113,827
27/08/26 US$33.41 -0.12% 436,785
26/08/26 US$33.45 +0.69% 627,177
25/08/26 US$33.22 -4.15% 667,014
24/08/26 US$34.66 -2.59% 512,006
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
33.41USD
Average target price
57.86USD
Spread / Average Target
+73.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock